Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45002Not yet recruiting
Randomised, double-blind trial of flucloxacillin in cellulitis and erysipelas (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Resolution of cellulitis at 14 days. Planned start Feb 2013; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45002.